Related Experiment Video
Updated: Feb 27, 2026

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
AXIN1 protects against testicular germ cell tumors via the PI3K/AKT/mTOR signaling pathway
Hailiang Xu1, Yunyun Feng2, Zhankui Jia3
1Department of Urinary Surgery, The Zhumadian City Center Hospital, Zhumadian, Henan 463000, P.R. China.
Abstract:
Axis inhibition protein 1 (AXIN1) is characterized as a tumor suppressor in numerous types of cancer. However, the functional role of AXIN1 in the testicular germ cell tumors (TGCTs) remains unclear. The human embryonal carcinoma-derived cell line NTera2 was transfected with a recombinant AXIN1 expression vector (pcDNA3.1-AXIN1) and/or a small interfering RNA (siRNA) directed against AXIN1 (siAXIN). Following transfection, the mRNA and protein levels of AXIN1 were determined via reverse transcription-quantitative polymerase chain reaction analysis and western blotting, respectively. In addition, cell viability, apoptosis and the expression of apoptosis-associated proteins [apoptosis regulator Bax (Bax) and B-cell lymphoma (Bcl)-2] and phosphatidylinositol 3-kinase (PI3K)/protein kinase B (AKT)/mammalian target of rapamycin (mTOR) signaling pathway proteins [phosphorylated (p)-mTOR, mTOR, p-AKT, AKT, P-70S ribosomal protein S6 (S6) and S6] were assessed. AXIN1 mRNA and protein levels were increased following transfection with pcDNA3.1-AXIN1 and decreased following transfection with siAXIN1 compared with their respective control groups. After overexpression of AXIN1, NTera2 cell viability and expression of Bcl-2, p-mTOR p-AKT and p-S6 protein was decreased, while apoptosis and Bax protein levels were increased, compared with the control group. However, there was no significant difference in AXIN1 mRNA expression, apoptosis or Bax/Bcl-2 protein expression when NTera2 cells were simultaneously transfected with pcDNA3.1-AXIN1+siAXIN1. In conclusion, the results of the present study indicate that overexpression of AXIN1 protects against TGCTs via inhibiting the PI3K/AKT/mTOR signaling pathway, suggesting that AXIN1 may be a potential target for gene therapy in TGCTs.
Insights
Axis inhibition protein 1 (AXIN1) acts as a tumor suppressor in testicular germ cell tumors (TGCTs). Overexpressing AXIN1 inhibits the PI3K/AKT/mTOR pathway, reducing cell viability and promoting apoptosis in TGCTs.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Genetics
Background:
- Axis inhibition protein 1 (AXIN1) is a known tumor suppressor in various cancers.
- The specific role of AXIN1 in testicular germ cell tumors (TGCTs) is not well-understood.
Purpose of the Study:
- To investigate the functional role of AXIN1 in TGCTs using the NTera2 cell line.
- To determine the effect of AXIN1 overexpression on TGCT cell behavior and signaling pathways.
Main Methods:
- NTera2 cells were transfected with AXIN1 expression vectors or siRNA.
- AXIN1 mRNA and protein levels were quantified using RT-qPCR and Western blotting.
- Cell viability, apoptosis, and key protein expressions (Bax, Bcl-2, PI3K/AKT/mTOR pathway) were assessed.
Main Results:
- AXIN1 overexpression increased apoptosis and Bax levels while decreasing cell viability and Bcl-2 expression in NTera2 cells.
- AXIN1 overexpression suppressed the PI3K/AKT/mTOR signaling pathway, indicated by reduced p-mTOR, p-AKT, and p-S6.
- Simultaneous transfection with AXIN1 expression vector and siRNA did not yield significant changes, suggesting a dose-dependent effect.
Conclusions:
- AXIN1 overexpression exhibits a protective effect against TGCTs by inhibiting the PI3K/AKT/mTOR pathway.
- AXIN1 demonstrates potential as a therapeutic target for gene therapy in TGCTs.
More Related Videos
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The JAK-STAT Signaling Pathway
The Intrinsic Apoptotic Pathway
Abnormal Proliferation
DNA Damage can Stall the Cell Cycle

